Melissa Perez
Physician Assistant · McAllen, TXNPI 1114423746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 583 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,759 and has fallen 97.9% since, to $59 in 2025. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 583 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$896
- Boehringer Ingelheim$757
- Amarin Pharma, Inc.$692
- Lilly USA, LLC$690
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$564
- plus $4K from 38 others
What the payments were for
- Food & beverage$8,60399%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,688 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $90,438 |
| JardianceEmpagliflozin | 45 | $62,056 |
| RybelsusSemaglutide | 18 | $33,856 |
| SynjardyEmpagliflozin/Metformin Hcl | 21 | $29,330 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 22 | $28,061 |
| VascepaIcosapent Ethyl | 46 | $27,774 |
| FarxigaDapagliflozin Propanediol | 21 | $23,113 |
| KerendiaFinerenone | 15 | $19,427 |
| MyrbetriqMirabegron | 16 | $15,037 |
| JanuviaSitagliptin Phosphate | 11 | $14,479 |
| JentaduetoLinagliptin/Metformin Hcl | 13 | $14,230 |
| Icosapent Ethyl | 29 | $13,200 |
| LinzessLinaclotide | 14 | $12,563 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 21 | $9,713 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 13 | $2,994 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy, Synjardy Xr, Jentadueto | $757 | $133,678101 claims |
| Novo NordiskOzempic, Rybelsus | $1,118 | $124,29483 claims |
| AstraZenecaFarxiga | $896 | $23,11321 claims |
| BayerKerendia | $156 | $19,42715 claims |
| Astellas Pharma US IncMyrbetriq | $307 | $15,03716 claims |
| MerckJanuvia | $161 | $14,47911 claims |
| AbbVieLinzess | $563 | $12,56314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in McAllen
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
- Heidi JeffreysLubbock$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.